PRKACB Antikörper (C-Term)
Kurzübersicht für PRKACB Antikörper (C-Term) (ABIN7185425)
Target
Alle PRKACB Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from the C-terminal region of Human PKAbeta cat.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB:1:500-1:2000, IHC:1:100-1:300, ELISA:1:20000,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- PRKACB (Protein Kinase, CAMP Dependent, Catalytic, beta (PRKACB))
-
Andere Bezeichnung
- PRKACB
-
Hintergrund
- CAMP-dependent protein kinase catalytic beta subunit isoform 4ab antibody, cAMP-dependent protein kinase catalytic subunit beta antibody, KAPCB_HUMAN antibody, PKA C beta antibody, PKA C-beta antibody, PKACB antibody, Prkacb antibody, protein kinase A catalytic subunit beta antibody, Protein kinase cAMP dependent catalytic beta antibody
-
UniProt
- P22694
-
Pathways
- AMPK Signaling, Hedgehog Signalweg, EGFR Signaling Pathway, Neurotrophin Signalübertragung, Thyroid Hormone Synthesis, Myometrial Relaxation and Contraction, M Phase, G-protein mediated Events, Interaction of EGFR with phospholipase C-gamma, Lipid Metabolism
Target
-